Verona Pharma Plc Overview

Verona Pharma Plc Cost of Revenue

Cost of Revenue analysis for VRNA.

Quarterly Cost of Revenue

$4.76M

As of Jun 30, 2025

Annual Cost of Revenue (TTM)

$10.74M

↑ 1614.38% YoY

Trailing 12 months ending Jun 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin